CM
RETA

Castleark Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Castleark Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26,085
Closed -$3.77M – 397
2020
Q1 		$3.77M Buy
+26,085
New +$3.77M 0.22% 121